A B S T R A C T The combined effects of cortisol and agents acting through a cyclic AMP-mediated mechanism have been studied in cultures of highly purified human peripheral lymphocytes. Incubation with prostaglandin El (PGE1), dibutyryl cyclic AMP, or cortisol results in a concentration-dependent inhibition of [3H]-thymidine incorporation by both unstimulated and phytohemagglutinin (PHA) -stimulated lymphocytes, and PHA-induced morphologic transformation is prevented. When cortisol and PGE1 (or dibutyryl cyclic AMP) are added together to lymphocyte cultures, enhanced inhibitory effects are observed.
INTRODUCTION
Cultures of lymphocytes obtained from human peripheral blood maintain a low, stable rate of [3H]thymidine incorporation into DNA for longer than a week (1) .
When incubated with phytohemagglutinin (PHA),1 the majority of these cells undergo a morphologic transformation accompanied by a markedly increased rate of [3H]thymidine incorporation (2) . Studies of healthy individuals and of patients with a variety of illnesses have shown that the capacity for this transformation response to PHA correlates well with the donor's ability to generate a cellular (delayed) immune response (3) .
PHA-induced lymphocyte transformation can be diminished or prevented by incubating cultures with glucocorticosteroid hormones (416) . Recently it was observed that incubation with dibutyryl cyclic AMP or hormones which elevate intracellular cyclic AMP concentrations can also result in a suppressed response to PHA (7, 8) . Because corticosteroid hormones and hormones which act through a cyclic AMP-mediated mechanism have been shown to interact in a number of biochemical systems (9), we undertook to determine whether such an interaction could be demonstrated in human peripheral lymphocyte cultures. The effect of these hormones and of exogenous cyclic AMP upon both unstimulated and PHA-stimulated lymphocytes was assayed by measuring [8H]thymidine incorporation. In addition, measurements of intracellular cyclic AMP concentrations suggested a mechanism for the observed hormone interaction.
METHODS

Isolation of lymphocytes. Peripheral blood lymphocytes
were obtained from a unit of normal donor blood by previously reported methods (10) . The preparative steps 1Abbreviations used in this paper: cyclic AMP, cyclic adenosine 3',5'-monophosphate; dibutyryl cyclic AMP, NO,-0'2-dibutyryl cyclic adenosine 3',5'-monophosphate; PGE1, prostaglandin E1; PHA, phytohemagglutinin. Transformiation sti(dies. The lymphocytes were distributed in duplicate 1-ml cultures containing 1-4 X 106 cells in Eagle's minimal essential medium (Grand Island Biological Co., Grand Island, N. Y.) fortified with 10% autologous serum, 4 mM glutamine, 100 U/ml penicillin, and 100 Ag/ml streptomycin. Phytohemagglutinin-E, purified from Difco PHA-P (Difco Laboratories, Detroit, Mfich.) (11) , was used at a concentration of 5 ,ug/ml, which produced maximal transformation at 72 h under these conditions (10- After exposing slides to Kodak NTB emulsion (Eastman Kodak Co., Rochester, N. Y.) for 2 wk, grains were counted over 5-10 x 10' cells (12) . The DNA content per culture was measured by the method of Burton (13) .
Cyclic AMP assay. For these studies, 5-10 X 106 lymphocytes were suspended in 1-2 ml of complete inicubation medium (containing 10% autologous fresh serum) and additions of PHA, PGE,, and/or cortisol were then made. After further incubation for appropriate time intervals, the cultures were collected by centrifugation at 200 g for 3 min, and 1 ml of 5% TCA at 4°C was added immediately. The samples were frozen and thawed, sonicated, and centrifuged at 2,000 g for 15 min. The acid-soluble supernate was removed, extracted five times with ether to remove TCA, heated at 85°C for 30 min to remove the ether, and then stored at -20°C. Parallel extractions performed after addition of [3H]cyclic AMP showed that approximately 100% of free cyclic AMP was recovered. When replicate shortterm incubations were performed in the presence and absence of serum, it was found that intracellular cyclic AMP levels were reduced by more than 50% after 30 min incubation without serum. Cyclic AMP levels were slightly reduced when autologous fresh serum was replaced by fetal calf serum.
Cyclic AMP concentrations were measured by a competitive binding assay (14) 7 .0, and 0.1 M MgCl2. The filters were dissolved in 10 ml Bray's solution and counted in a liquid scintillation spectrometer. A standard curve was run with each assay. Each extract from a lymphocyte culture was assayed for cyclic AMP in duplicate, with agreement in the determined cyclic AMP levels usually to within 5%o. On occasion, when greater variation was observed, the assay was repeated. When extracts from paired lymphocyte cultures were assayed, the intracellular cyclic AMP concentrations agreed to within 14%.
The validity of the assay was verified by the following observations: (a) The measured concentration of cyclic AMP was shown to be independent of the number of cells in the lymphocyte cultures. (b) When known amounts of cyclic AMP were added to a portion from a previously assayed lymphocyte extract, the recovery of total cyclic AMP in a repeat assay was 95±9% (mean +SEM, n=7). Materials and reagents. Dibutyryl cyclic AMP (P-L Biochemicals, Inc., Milwaukee, Wis.) was extracted with ether at pH 2 to remove butyric acid (16) . The concentration of dibutyryl cyclic AMP was then determined spectrophotometrically. Cyclic AMP (P-L Biochemicals, Inc.) was neutralized with NaOH.
[3H]Cyclic AMP was obtained from New England Nuclear (Boston, Mass.) and the purity was verified by paper chromatography (17) . Cortisol (Sigma Chemical Co., St. Louis, Mo.) was dissolved in ethanol. PGE1 (lots 10323-JHK-71E and 10323-JHK-153A) was generously donated by Dr. John E. Pike (The Upjohn Co., Kalamazoo,, Mich.) and was dissolved in ethanol. Cyclic GMP was obtained from Boehringer Mannheim Corp. (New York). AMP, ADP, ATP, and cyclic AMP phosphodiesterase were from Sigma Chemical Co.
RESULTS
Effect of cyclic AMP, dibutyryl cyclic AMP, and PGE. upon lymphocytes. Studies were performed to determine the effects of agents acting through a cyclic (Fig. 1A) . At the highest inhibitory concentrations tested, incorporation was reduced to levels below 35% of untreated cultures. Similar studies of the effects of dibutyryl cyclic AMP and PGE1 upon cultures incubated with PHA demonstrate an even greater reduction in ['H]thymidine incorporation, confirming previously reported observations on PHA-stimulated lymphocytes (Fig. 1B) . The similarity of the dose-response curves when both unstimulated and stimulated cultures are exposed to these agents is apparent.
The cultured lymphocytes were examined morphologically to determine the incidence of blastic transformation under these experimental conditions. After incubation of the unstimulated lymphocytes for 72 h, blastic transformation into enlarged cells, with cytoplasm: nucleus ratios of > 1 and with greatly enlarged nuclei containing enlarged or multiple nucleoli, was limited to less than 2% of the cells. In contrast, PHA-stimulated cultures contained between 50 and 70% blastic transformed cells after 72 h of incubation. Incubation of PHA-treated cultures with dibutyryl cyclic ANIP or Experiments were performed to determine the effects of PGE1 and cortisol, alone and in combination, upon lymphocyte cyclic AMP levels (Table III) . Addition of 0.1 mM PGE1 resulted in a rapid elevation of intracellular cyclic AMP levels which peaked by [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] min, whereas at concentrations of 0.01-0.001 mMI PGE1, the response was variable. Cyclic ANIP levels rose 3.3±0.4- and with the combination of PGE1 plus cortisol.
A similar elevation of cyclic AMP levels in response to hormones was observed in lymphocyte cultures stimulated by the addition of PHA immediately before (or after) addition of hormones (Table IV ). The addition of 0.1 mM PGE1 resulted in a 2.6+-0.2-fold (mean +SEM, n = 7) rise in cyclic AMP levels after 20 min.
Cortisol further augmented the effect of PGE, resulting in a 3.7+0.4-fold increase in cyclic AMP levels, which is a statistically significant change (P = 0.02). In a larger series of experiments, cyclic AMP levels were measured 20 min after addition of PHA to lymphocyte cultures paired with unstimulated cultures from the same donor. In the presence of PHA, a 1.3±0.16-fold (mean -+-SEM, n = 23) rise in cyclic AMP levels was observed, which is not a statistically significant change (0.1 > P>0.05).
The kinetics of changes in lymphocyte intracellular cyclic AMP levels, in response to PGE1 and cortisol, are shown in Fig. 3 . In this case, the response of PHAstimulated cultures is plotted; a similar time course was observed with unstimulated cultures. The peak elevation in cyclic AMP levels was observed at the earliest time point, 20 min after addition of PGE1. During the next 1-6 h, the concentrations gradually declined to nearly base-line levels. The kinetics of intracellular cyclic AMP concentrations followed a similar pattern when the levels were further augmented by the interaction of cortisol with PGE1 (Fig. 3) .
The enhanced response to PGE1, induced by addition of cortisol to lymphocyte cultures, was further characterized by experiments summarized in Table V . The data in Table VA are from two experiments that demonstrate concentration dependence of the augmented cyclic AMP stimulation induced by simultaneous addition of PGE1 and cortisol to lymphocyte cultures. Dexamethasone can substitute for cortisol in stimulating a further response to PGE1 (Table VB) . However, the steroid molecule, cholesterol, in similar concentrations, does not augment the effect of PGE1 upon lymphocyte cyclic AMP levels (Table VC) . Addition of ethanol (solvent for hormones) to cultures caused inconsequential changes in cyclic AMP levels (Table VD) . DISCUSSION Our studies with both unstimulated and PHA-stimulated lymphocyte cultures demonstrate that [8H]thymidine incorporation into lymphocyte DNA is regulatable by a glucocorticoid hormone and by agents acting through a cyclic AMP-mediated mechanism. Morphologic transformation by PHA was also prevented by these agents. The observations on PHA-stimulated cultures confirm previous reports (4) (5) (6) (7) (8) . At the initiation of in vitro cultures, peripheral small lymphocytes are felt to be in a resting or Go phase of the cell cycle (19) . The function of DNA synthesized by unstimulated peripheral lymphocytes in short-term culture has not been explored. It could be due to stimulation of a very small proportion of the cultured cells by exogenous stimuli in the medium, or it may represent repair synthesis. The nature and function of DNA synthesized after PHA stimulation is also not fully understood. Some newly synthesized DNA may subsequently be FIGuRE 3 Changes in lymphocyte cyclic AMP levels in response to hormones. Replicate cultures of lymphocytes were incubated in complete medium in the presence of PHA. Additions of hormones were made to the appropriate cultures initially. After the designated periods of incubation, the cultures were harvested for assays of cyclic AMP levels, as described in Methods.
removed from transformed cells (20, 21) . However, at least a portion of it must be utilized for genome replication, since an increase in the mitotic rate of PHAtransformed lymphocytes has been observed (22) .
We observed cooperative inhibitory effects of cortisol and agents acting through cyclic AMP. Incubation of lymphocytes with cortisol alone did not significantly alter intracellular cyclic AMP concentrations. However, when cortisol was added to cultures concomitant with PGE1, we observed a rapid further rise in cyclic AMP concentrations to levels higher than with PGE1 alone. Thus cortisol may augment the suppressive effects of PGE1 upon lymphocytes through a mechanism involving further elevation of intracellular cyclic AMP concentrations. Whether the observed increase in cyclic AMP levels is due to increased adenyl cyclase activity, inhibition of phosphodiesterase, or a more indirect mechaism remains to be tested and is the subject of further investigation in this laboratory. Since the potentiation of PGEi-induced rises in cyclic AMP levels occurred within minutes, the mechanism is unrelated to the events associated with glucocorticosteroid-stimulated synthesis of specific proteins, which involves increased transcription of messenger RNA as a result of steroidreceptor complex binding to DNA (23) . It should be stressed that the further stimulation of PGE,-induced increases in cyclic AMP levels does not account for the inhibitory effect of cortisol when added alone to peripheral lymphocyte cultures. The varied effects of cortisol upon biochemical events in different lymphocyte populations have been reviewed recently (24) .
Interactions between glucocorticosteroid hormones and agents acting through cyclic AMP have been described in a variety of experimental systems. The mechanism of this interaction is not understood, and a "permissive" role of corticosteroids has been postulated (see reference 9). This was attributed to a decrease in cyclic AMP phosphodiesterase activity in a recent study of cultured hepatoma cells (25) . A requirement for glucocorticoids in the stimulation of increased adenyl cyclase activity by isoproterenol has been demonstrated in a recent study of cultured peripheral leukocytes from asthmatic patients (26) . Our data on lymphocytes from normal donors indicate that interaction between cortisol and agents stimulating increased cyclic AMP levels may be a more general phenomenon, which could possibly be exploited in clinical situations where lymphocyte suppression is desirable.
Exogenous cyclic AMP and dibutyryl cyclic AMP, in low concentrations, have been implicated as primary stimulators of peripheral lymphocyte transformation (7, 8, 27) . In each of these reports, small increases in
[3H]thymidine incorporation were observed. We find no evidence that cyclic AMIP, in concentrations ranging from 1 nM to 1 mMA, stimulates a significant increase in [3H]thymidine incorporation, a conclusion in agreement with the findings of Novogrodsky and Katchalski (28) .
Wlhen cultures exposed to optimal concentrations of PHA were compared with unstimulated cultures, a small rise in cyclic AMP levels Nas often observed, but statistical analysis showed this to be nonsignificant. Smith, Steiner, Newberrv, and Parker (29) , demonstrated a transient stimulation of human lymphocyte cyclic ANIP levels by a range of PHA concentrations which were in many cases far higher than those used to induce lymphocyte transformation and which can inhibit optimal transformation. Within 1-6 h, the cyclic AMP levels in PHA-stimulated lymphocytes fell to below the levels in control cultures (29) . Others have not observed an early rise in intracellular cyclic AMP after stimulation with various preparations of PHA (28, 30) . The observation that incubation of both unstimulated and PHA-stimulated lymphocytes with PGE1 resulted in early elevation of cyclic AMP levels and marked inhibition of ['H]thymidine incorporation supports the conclusion reached by Smith et al. (29) , that elevated intracellular cyclic AMP levels are associated with inhibition of peripheral lymphocyte nucleic acid synthesis and transformation. Hormone-induced stimulation of lymphocyte cyclic AMP levels also has been found to inhibit the cytotoxic activity of lymphocytes from preimmunized animals against allogeneic cells in vitro (31, 32) .
Support for a general role of cyclic AMP in controlling cell division and cell differentiation is derived from recent studies with permanent cell culture lines. The doubling time of 3T3 cells correlates with intracellular cyclic AMP levels (33) . Incubation of a permanent Chinese hamster ovarian fibroblast line with dibutyryl cyclic AMP has been shown to induce contact inhibition of growth and reacquisition of an elongated fibroblast-like nmorplhology, with initiation of collagen synthesis (34) . In this case, as in our studies, the response to an agent raising intracellular cyclic AMP levels was augmented by concurrent exposure to a steroid hormiione, testosterone.
